These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 5718774)

  • 1. Effect of a new adrenergic beta-blocking agent (ICI 50,172) on heart rate in relation to its blood levels.
    Fitzgerald JD; Scales B
    Int Z Klin Pharmakol Ther Toxikol; 1968; 1(6):467-74. PubMed ID: 5718774
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of 4-(2-hydroxy-3-isopropylaminopropoxy) acetanilide (AY 21,011) on the myocardial and coronary vascular responses to adrenergic stimulation.
    Lucchesi BR; Hodgeman RJ
    J Pharmacol Exp Ther; 1971 Jan; 176(1):200-11. PubMed ID: 4398216
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of the effects of propranolol and MJ 1999 on cardiac beta-adrenoceptors in man.
    Kofi Ekue JM; Lowe DC; Shanks RG
    Br J Pharmacol; 1970 May; 38(3):546-53. PubMed ID: 4392540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacology of M & B 17803A in man and dog.
    Briant RH; Dollery CT; Fenyvesi T; George CF
    Br J Pharmacol; 1971 Oct; 43(2):468P-469P. PubMed ID: 4400577
    [No Abstract]   [Full Text] [Related]  

  • 5. Adrenergic blocking properties of MJ 1999 and butoxamine on cardiac and vascular beta-receptors.
    Wilkenfeld BE; Levy B
    Arch Int Pharmacodyn Ther; 1968 Nov; 176(1):218-32. PubMed ID: 5709786
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of the cardioselective beta-receptor blocker (ICI 50172) on hemodynamics and oxygen consumption of the left ventricle in the dog (whole animal)].
    Bussmann WD; Krayenbühl HP
    Helv Physiol Pharmacol Acta; 1968; 26(2):CR 199+. PubMed ID: 5723448
    [No Abstract]   [Full Text] [Related]  

  • 7. [Absence of antiarrhythmic activity of 2 adrenergic beta-blockers detected by an association of pharmacological methods].
    Vargaftig BB; Coignet JL
    Therapie; 1969; 24(5):853-8. PubMed ID: 4391431
    [No Abstract]   [Full Text] [Related]  

  • 8. Preliminary investigations of a new beta-adrenoceptive receptor blocking drug, LB46, in man.
    Hill RC; Turner P
    Br J Pharmacol; 1969 Jun; 36(2):368-72. PubMed ID: 5787671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of cardiac effects of isoproterenol by the stereoisomers of sotalol.
    Somani P; Bachand T
    Eur J Pharmacol; 1969 Sep; 7(3):239-47. PubMed ID: 4390869
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of graded doses of practolol on the tachycardia induced by isoprenaline, Valsalva's manoeuvre and exercise.
    Aellig WH; Prichard BN
    Br J Pharmacol; 1970 May; 39(1):193P-194P. PubMed ID: 4392962
    [No Abstract]   [Full Text] [Related]  

  • 11. Sotalol: a new, safe beta adrenergic receptor blocking agent.
    Frankl WS; Soloff LA
    Am J Cardiol; 1968 Aug; 22(2):266-72. PubMed ID: 5665858
    [No Abstract]   [Full Text] [Related]  

  • 12. Sympathomimetic action of an adrenergic beta receptor blocking agent, 4-(2-isopropylamino-1-hydroxyethyl) methanesulphonanilid hydrochloride (MJ1999).
    Agarwal SL; Bose D; Natu MV; Gandhi IS
    Indian J Med Res; 1968 Feb; 56(2):227-33. PubMed ID: 5657521
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparative studies on the influence of beta-receptor blocking agents on different circulatory parameters. I. Experimental results before, during and after loading].
    Kirchhoff HW; Kuemmerle HP; von Düsterlho J
    Int Z Klin Pharmakol Ther Toxikol; 1969 Jul; 2(3):229-45. PubMed ID: 4391093
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hemodynamic effects of a new beta-adrenergic blocking agent. Study of normal subjects in various cardiocirculatory functional conditions].
    Starcich R; Barbaresi F; Bacuzzi E; Valentino RV
    Minerva Cardioangiol; 1966 Nov; 14(11):650-7. PubMed ID: 5999111
    [No Abstract]   [Full Text] [Related]  

  • 15. Antiarrhythmic activity of the dextro- and levorotatory isomers of 4-(2-isopropylamino-1-hydroxyethyl) methanesulfonanilide (MJ 1999).
    Somani P; Watson DL
    J Pharmacol Exp Ther; 1968 Dec; 164(2):317-25. PubMed ID: 5699093
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical-pharmacological studies with a new beta receptor blocking substance (LB 46, Visken)].
    Judmaier G; Dienstl F; Schwingshackl H; Amor H
    Wien Klin Wochenschr; 1970 Dec; 82(50):891-3. PubMed ID: 5491146
    [No Abstract]   [Full Text] [Related]  

  • 17. The effects of a new beta-adrenoceptive receptor blocking drug on heart rate in man.
    Hill RC; Turner P
    Br J Pharmacol Chemother; 1968 Mar; 32(3):663-70. PubMed ID: 4868660
    [No Abstract]   [Full Text] [Related]  

  • 18. [Changes in oxygen consumption after beta-adrenergic block].
    Leonardis G; Splendiani G; Ventura T
    Minerva Anestesiol; 1970 May; 36(5):303-6. PubMed ID: 4394230
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on dl-4-(2-hydroxy-3-isopropylaminopropoxy)-indole A/Giudicelli JF, Schmitt H, Boissier JR: Studies on dl-4-(2-hydroxy-3-isopropylaminopropoxy)-indole (LB 46), a new potent beta adrenergic blocking drug.
    Giudicelli JF; Schmitt H; Boissier JR
    J Pharmacol Exp Ther; 1969 Jul; 168(1):116-26. PubMed ID: 5792677
    [No Abstract]   [Full Text] [Related]  

  • 20. [The effect of beta-receptor-blocking agents on the ergometric performance study in hypertensive regulation disorders and hyperkinetic heart syndrome].
    Enenkel W; Polzer K; Kubicek F
    Wien Med Wochenschr; 1968 Oct; 118(42):874-6. PubMed ID: 5708730
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.